secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158321
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology shareholders elect directors and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Owen Hughes elected as Class III director with 22,250,184 votes for, 4,967,774 withheld.
- Mark Manfredi elected as Class III director with 24,738,833 votes for, 2,479,125 withheld.
- Ernst & Young ratified as auditor for FY2024 with 34,421,661 for, 31,819 against, 11,827 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/0001193125-24-158321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312524158321/d837508d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer